. Chemical control of the cardiovascular system during surgery. Biochem. clin., In press TISSUE TRANSPLANTATION Never before has interest in transplantation of tissues been so intense. Throughout the world the volume of research into tissue grafting, tissue immunology, organ transplantation and tissue storage is probably secondary only to that in the field of cancer. The successful surmounting of the homograft reaction, the ability to transplant freely from one individual to another with spares and replacements readily available for every organ is the glittering prize which is attracting clinicians, biologists, immunologists and geneticists to a problem which becomes ever Leading Article more complex the more it is explored. The flow of literature increases continuously and it is now almost beyond the scope of any individual to keep in touch with the many ramifications of the subject. Partly for this reason and partly because of its topicality, tissue transplantation was the subject of a two and a half day symposium held in November 1962, in the Royal Faculty of Physicians and Surgeons of Glasgow under the auspices of the Glasgow Postgraduate Medical Board; a summary is published on page 153 of this issue of the Scottish Medical Journal.
The homograft-rejection phenomenon fits into the general pattern of an immune response. It occurs after an interval of healthy survival and second grafts from the same donor are destroyed more quickly than the first. But it differs from most immune reactions in that soluble circulating antigens and antibodies play little or no part. It occurs only if there is cellular contact between host and graft and the host cells most intimately concerned are the small lymphocytes. Only two tissues, cartilage and cornea, reliably survive homografting. Chondrocytes in rib and ear cartilage protected from cellular contact by the mucopolysaccharide matrix have been found to be alive years after transplantation and such homografts are valuable in reconstructive surgery. The recent demonstration that articular cartilage behaves similarly may permit the resurfacing of joints in certain arthritic conditions. Corneal cells are also protected by the matrix although a number of corneal grafts become opaque at a late stage, particularly if vascularised. The solution of the technical problems offull thickness corneal grafts has greatly widened the indications for their use.
Apart from cartilage and cornea, only skin has been much used clinically as a homograft and then purely as a temporary epithelial cover in very extensive burns. The fact that the inert skeletal elements of other tissues will persist after the cells have been destroyed enables homografts. of bone and blood vessels to be used with some clinical success, but on the whole they are inferior to autografts.
At the time of writing, there is still no sign of any simple clinical technique which might circumvent homograft rejection. In fact, each hopeful advance has been followed by unforeseen complications. The discovery of immunological 'tolerance' for instance, seemed at first to presage success. Until late in intra-uterine life and in some species until shortly after birth, young mammals cannot distinguish between their own and foreign proteins, between 'self' and 'not self'. If they are injected with living cells from a prospective donor at this stage they become tolerant and will accept homografts from the donor later in life. But only living cells which are themselves immunologically competent will reliably induce tolerance and in a high proportion of cases they also produce a graftversus-host reaction which eventually destroys the host. A cell-free antigen which would induce tolerance is one possible but rather impractical solution of the homograft problem; impractical because the prospective donor would have to supply antigen at or before the birth of the host.
Known ways of preventing the homograft reaction are either of academic interest only or involve such profound interference with vital functions that they have few clinical applications. As an example, the lymphocytes which mediate the reaction may be destroyed or inhibited by total body irradiation or cytotoxic drugs. This has been used in man to prolong the survival of homografts of the kidney, an organ which exists in duplicate and whose biood supply enables it to be readily transplanted by vascular anastomosis. The immediate dramatic improvement in patients dying from renal disease has been widely publicised and in many cases longer than usual survival of the grafts has occurred. But OBITUARY A. L. Goodall Mr Archibald Lamont Goodall, whose sudden death on 17th March 1963, shocked'a wide circle of friends and acquaintances, was well known throughout Britain and many countries overseas as an international authority on surgery, the teaching of surgery, the history of medicine and medicallibrarianship. Throughout his professional life he suffered from chronic ill-health which denied him the pro-the long-term results are disappointing and Hume in October 1962 reported at the Annual Congress of the American College of Surgeons in Atlantic City that of the sixty-five homografts known to have been performed until then only three had survived longer than 1 year. Thus it is still debatable whether the procedure is fully justified in the present state of our knowledge. Certainly the destruction wholly or in part of a patient's haemopoietic and reticulo-endothelial tissue is far too drastic a preparation for the majority of homografts we would like to use.
The techniques of transplantation are highly developed; in addition to the kidney, the heart and lungs and the whole head of a dog have been transplanted by vascular anastomosis with temporary survival until the homograft reaction occurred. Storage of tissues ii: a viable state is also being widely studied. Cooling to just above freezing prolongs survival considerably but not permanently. Pretreatment with glycerol or dimethyl sulphoxide will protect certain cells against the inevitable death which occurs on freezing and allow them to be kept viable for months or years. This is particularly so when the tissue consists of discrete cells as in the case of spermatozoa, but it is not yet reliable for compound or bulky tissues.
The exact nature of the homograft reaction remains elusive and until it is known and simple methods of circumventing it are available, much of this technical knowledge will be without practical application. If and when we can use it to the full the demand will be enormous and one major new problem will arise; whence comes the supply? motion he might otherwise have obtained. Indeed, for some years he had known that his was borrowed time and the end could not long be delayed. Yet he threw himself with such whole-hearted energy and enthusiasm into all he undertook that his colleagues forgot or never realised his precarious tenure of life. That he might have extended this by taking things easily never occurred to him; he was an idealist who, with so little time left, saw so much to do and used every moment to the full.
